Immunology and autoimmune disease
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- ACADEMISCH ZIEKENHUIS LEIDEN
Major Dutch academic hospital leading European research in immunology, regenerative medicine, medical imaging, and biomarker-driven precision medicine.
“Deep involvement in type 1 diabetes (INNODIA, BetaCellTherapy), rheumatoid arthritis, vaccine development (VSV-EBOVAC, TBVAC2020), and immunotherapy across dozens of projects.”
PrimaryNL156 projects - KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
TU Munich's university hospital: translational research in oncology, neuroscience, and precision diagnostics with strong ERC track record and advanced imaging capabilities.
“GCB-PRID (germinal center B cells), IMCIS (inflammatory skin diseases), NORVAS (vascular disease), and SVDs-at-target demonstrate expertise in immune mechanisms underlying chronic disease.”
DE49 projects - BRIGHAM INC
Harvard-affiliated Boston hospital providing biomedical research hosting for EU fellows in cancer, neuroscience, nanotechnology, and organ-on-chip platforms.
“DANTE investigated pathogenic TH17 cells in multiple sclerosis; STOPFOP ran a clinical trial for fibrodysplasia ossificans progressiva.”
PrimaryUS9 projects